Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Medical cannabis - the Canadian perspective.
Inhaled Sargramostim Induces Resolution of Pulmonary Alveolar Proteinosis in Lysinuric Protein Intolerance.
A Risk Score for Predicting Multiple Sclerosis.
PolyAdenine cryogels for fast and effective RNA purification.
Repeated mild traumatic brain injury: potential mechanisms of damage.
Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films.
Progesterone treatment modulates mRNA OF neurosteroidogenic enzymes in a murine model of multiple sclerosis.
The Differential Effects of Alcohol and Nicotine-Specific Nitrosamine Ketone on White Matter Ultrastructure.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.
In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis.
Symptom Management and Lifestyle Modifications in Multiple Sclerosis.
Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.
Cortical Volume Loss and Neurologic Dysfunction in Multiple Sclerosis.
[Endogenous retroviruses are associated with autoimmune diseases].
Postural Sway In Persons With Multiple Sclerosis During Passive Heat Exposure: 2018 Board #170 June 2, 2: 00 PM - 3: 30 PM.
Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis.
Mobitz type I and II atrioventricular blocks during fingolimod therapy.
Astrocytes in Oligodendrocyte Lineage Development and White Matter Pathology.
Recurrent myelopathy and optic neuritis associated with systemic lupus erythematosus.
Exploring the feasibility and acceptability of sensor monitoring of gait and falls in the homes of persons with multiple sclerosis.
Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination.
Pediatric multiple sclerosis: Cognition and mood.
Effect of cognitive behavioral therapy on MS patients' quality of life. A multi-centre controlled trial.
The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis.
Pages
« first
‹ previous
…
812
813
814
815
816
817
818
819
820
…
next ›
last »